- Home
- IGC vs TRSG Comparison
IGC vs TRSG Comparison
Compare IGC & TRSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- TRSG
- Stock Information
- Founded
- IGC 2005
- TRSG 1996
- Country
- IGC United States
- TRSG Singapore
- Employees
- IGC N/A
- TRSG N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- TRSG
- Sector
- IGC Health Care
- TRSG
- Exchange
- IGC Nasdaq
- TRSG NYSE
- Market Cap
- IGC 29.4M
- TRSG 25.8M
- IPO Year
- IGC N/A
- TRSG 2024
- Fundamental
- Price
- IGC $0.31
- TRSG $1.64
- Analyst Decision
- IGC Strong Buy
- TRSG
- Analyst Count
- IGC 2
- TRSG 0
- Target Price
- IGC $3.88
- TRSG N/A
- AVG Volume (30 Days)
- IGC 392.1K
- TRSG 3.7K
- Earning Date
- IGC 02-18-2025
- TRSG 12-31-2024
- Dividend Yield
- IGC N/A
- TRSG N/A
- EPS Growth
- IGC N/A
- TRSG N/A
- EPS
- IGC N/A
- TRSG N/A
- Revenue
- IGC $1,236,000.00
- TRSG $14,441,864.00
- Revenue This Year
- IGC N/A
- TRSG N/A
- Revenue Next Year
- IGC $18.34
- TRSG N/A
- P/E Ratio
- IGC N/A
- TRSG N/A
- Revenue Growth
- IGC 1.64
- TRSG 9.34
- 52 Week Low
- IGC $0.26
- TRSG $1.56
- 52 Week High
- IGC $0.91
- TRSG $11.78
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- TRSG N/A
- Support Level
- IGC $0.26
- TRSG N/A
- Resistance Level
- IGC $0.34
- TRSG N/A
- Average True Range (ATR)
- IGC 0.02
- TRSG 0.00
- MACD
- IGC 0.01
- TRSG 0.00
- Stochastic Oscillator
- IGC 65.88
- TRSG 0.00
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.